FTY720 enhances the efficacy of paclitaxel and of carboplatin in drug-resistant ovarian cancer cells

被引：0
|
作者：
Kreitzburg, Kelly M.
Alvarez, Ronald D.
Landen, Charles N.
Yoon, Karina J.
机构：
来源：
CANCER RESEARCH | 2016年 / 76卷
关键词：
D O I：
10.1158/1538-7445.AM2016-316
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
316
引用
收藏
页数：3
相关论文
共 50 条
  • [41] The phosphorylated prodrug FTY720 is a histone deacetylase inhibitor that reactivates ERα expression and enhances hormonal therapy for breast cancer
    N C Hait
    D Avni
    A Yamada
    M Nagahashi
    T Aoyagi
    H Aoki
    C I Dumur
    Z Zelenko
    E J Gallagher
    D Leroith
    S Milstien
    K Takabe
    S Spiegel
    Oncogenesis, 2015, 4 : e156 - e156
  • [42] Kuguacin J isolated from bitter melon leaves modulates paclitaxel sensitivity in drug-resistant human ovarian cancer cells
    Pornsiri Pitchakarn
    Sonthaya Umsumarng
    Sariya Mapoung
    Pisamai Ting
    Piya Temviriyanukul
    Wanisa Punfa
    Wilart Pompimon
    Pornngarm Limtrakul
    Journal of Natural Medicines, 2017, 71 : 693 - 702
  • [43] Kuguacin J isolated from bitter melon leaves modulates paclitaxel sensitivity in drug-resistant human ovarian cancer cells
    Pitchakarn, Pornsiri
    Umsumarng, Sonthaya
    Mapoung, Sariya
    Ting, Pisamai
    Temviriyanukul, Piya
    Punfa, Wanisa
    Pompimon, Wilart
    Limtrakul, Pornngarm
    JOURNAL OF NATURAL MEDICINES, 2017, 71 (04) : 693 - 702
  • [44] Combination treatment of FTY720 and cisplatin exhibits enhanced antitumour effects on cisplatin-resistant non-small lung cancer cells
    Li, Yang
    Hu, Tinghua
    Chen, Tianjun
    Yang, Tian
    Ren, Hui
    Chen, Mingwei
    ONCOLOGY REPORTS, 2018, 39 (02) : 565 - 572
  • [45] Pitavastatin is a potential treatment for drug-resistant ovarian cancer
    Robinson, E.
    Jones, S.
    Menezes, K.
    Abdullah, M.
    Stronach, E.
    Hoskins, C.
    Richardson, A.
    EUROPEAN JOURNAL OF CANCER, 2016, 61 : S192 - S192
  • [46] Epigenetics, cell cycle and drug-resistant ovarian cancer
    Safuwan, Nur Arnida Mohammed
    Chivers, Pritlata
    Crook, Tim
    Syed, Nelofer
    Coley, Helen M.
    CANCER RESEARCH, 2012, 72
  • [47] EXPERIENCE OF WEEKLY DOSE DENSE CARBOPLATIN AND PACLITAXEL IN PLATINUM RESISTANT OVARIAN CANCER
    Roxburgh, P.
    Sharma, R.
    Brooks, A.
    Reed, N.
    Gabra, H.
    Glasspool, R.
    ANNALS OF ONCOLOGY, 2008, 19 : 212 - 212
  • [48] Effects of phosphorylation of immunomodulatory agent FTY720 (fingolimod) on antiproliferative activity against breast and colon cancer cells
    Nagaoka, Yasuo
    Otsuki, Kota
    Fujita, Tetsuro
    Uesato, Shinichi
    BIOLOGICAL & PHARMACEUTICAL BULLETIN, 2008, 31 (06) : 1177 - 1181
  • [49] FTY720 enhances the activation-induced apoptosis of donor T cells and modulates graft-versus-host disease
    Hashimoto, Daigo
    Asakura, Shoji
    Matsuoka, Ken-ichi
    Sakoda, Yukimi
    Koyama, Motoko
    Aoyama, Kazutoshi
    Tanimoto, Mitsune
    Teshima, Takanori
    EUROPEAN JOURNAL OF IMMUNOLOGY, 2007, 37 (01) : 271 - 281
  • [50] FTY720, a synthetic compound from Isaria sinclairii, inhibits proliferation and induces apoptosis in pancreatic cancer cells
    Shen, Yan
    Cai, Minxia
    Xia, Weiliang
    Liu, Junwei
    Zhang, Qiyi
    Xie, Haiyang
    Wang, Chen
    Wang, Xiaohui
    Zheng, Shusen
    CANCER LETTERS, 2007, 254 (02) : 288 - 297
12345